Home Article Dexcom G7 15 Day receives Health Canada authorization

Dexcom G7 15 Day receives Health Canada authorization

Dexcom G7 15 Day receives Health Canada authorization

Also Noted

Default Author Head Shot

By HME News Staff

Updated 10:48 AM CDT, Wed July 15, 2026

BURNABY, British Columbia – Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System for adults with diabetes. The system provides real-time glucose readings for up to 15.5 days, including a 12-hour grace period for replacing a finished sensor. Dexcom says the extended wear time will reduce the number of monthly sensor changes and the amount of related waste. “Small improvements can make a meaningful difference for people living with diabetes,” said André Côté, vice president and general manager of Dexcom Canada. “Dexcom G7 15 Day reflects our ongoing commitment to simpler, more seamless diabetes management.” While authorized by Health Canada, Dexcom G7 15 Day is not yet available for purchase in Canada.

Comments

To comment on this post, please log in to your account or set up an account now.